Composition for the prevention, improvement, or treatment of sarcopenia, comprising mealworm larval protein or its hydrolysate as an active ingredient

Mealworm Larval Protein-Based Composition for Sarcopenia, Inhibiting Myostatin Expression

This technology relates to a pharmaceutical, food, health functional food, or feed composition for the prevention, improvement, or treatment of sarcopenia, comprising mealworm larval protein or its hydrolysate as an active ingredient.

While muscle function decline and muscle loss significantly reduce quality of life, there have been limited materials capable of safely inhibiting muscle loss with long-term intake.

The mealworm larval protein in this technology effectively inhibits myostatin expression, a key factor in muscle loss, allowing it to be widely utilized as a material for addressing muscle diseases in various industries, including pharmaceuticals, food, and feed.

‍

‍

Key Features:

• Contains mealworm larval protein or its hydrolysate as an active ingredient
• Suppression of muscle loss by inhibiting myostatin expression
• Applicable in various formulations, including pharmaceuticals, food, health functional foods, and feed
• Addresses a wide range of muscle diseases, including muscle function decline, muscle atrophy, and muscle wasting